GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
0.8004
-0.0046 (-0.57%)
At close: Sep 15, 2025, 4:00 PM EDT
0.7900
-0.0104 (-1.30%)
Pre-market: Sep 16, 2025, 5:02 AM EDT
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $2.85 million as of September 16, 2025. Its market cap has decreased by -43.06% in one year.
Market Cap
2.85M
Enterprise Value
-2.38M
1-Year Change
-43.06%
Ranking
Category
Stock Price
$0.80
Market Cap Chart
Since October 18, 1983, GT Biopharma's market cap has decreased from $937.50M to $2.85M, a decrease of -99.70%. That is a compound annual growth rate of -12.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 2.86M | -57.98% |
| Dec 31, 2024 | 6.81M | -35.48% |
| Dec 29, 2023 | 10.56M | -63.37% |
| Dec 30, 2022 | 28.84M | -69.01% |
| Dec 31, 2021 | 93.05M | 159.67% |
| Dec 31, 2020 | 35.83M | 556.05% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |